OxyNorm® Capsules (Immediate-Release) Pharmacokinetic (PK) Study
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
A Single Dose PK Study of OxyNorm® immediate-release capsules 5, 10, and 20mg, and a
multiple-dose PK Study of OxyNorm® immediate-release capsules 10mg in Chinese patients with
pain.It will be a single center, open label, randomized, oral administration study.